1. Glennie, M. J. and Johnson, P. W. 2000. Clinical trials of antibody therapy. Immunol. Today21:403,
2. Saleh, M. N., Khazaeli, M. B., Wheeler, R. H., Dropcho, E., Liu, T., Urist, M., Miller, D. M., Lawson, S., Dixon, P. and Russell, C. H. 1992. Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res.52:4342.
3. Frodin, J. E., Lefvert, A. K. and Mellstedt, H. 1990. Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules. Cancer Res.50:4866.
4. Borrebaeck, C. K., Malmborg, A. C. and Ohlin, M. 1993. Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics? Immunol. Today14:477.
5. Junghans, R. P. 1999. Anti-Gal antibodies—where's the beef? Nat. Biotechnol.17:938.